Speaker Details

Adam J. Friedman, MD, FAAD

Adam J. Friedman, MD, FAAD

SESSIONS

F043 Treating Tumors and Inflammatory Skin Diseases with Immunomodulators and Biologics
Mar 9, 2024 • 9:00 AM - 12:00 AM • Room 28D

HANDOUTS

Login to view handouts

DISCLOSURES

AbbVie – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); BMS – Speaker(Honoraria); CeraVe – Other(Grants/Research Funding); Eli Lilly – Other(Grants/Research Funding), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria); Galderma – Other(Grants/Research Funding), Speaker(Honoraria); Galderma USA – Consultant(Honoraria); Hoth Therapeutics – Advisory Board(Honoraria); Incyte – Data Safety Monitoring Board(Honoraria), Speaker(Honoraria); janssen – Other(Grants/Research Funding); Janssen Biotech – Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Johnson and Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Advisory Board(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria), Consultant(Honoraria); Medscape – Speaker/Faculty Education(Honoraria); Novartis – Advisory Board(Honoraria); Orlando Dermatology Aesthetic & Clinical (ODAC) – Speaker(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Honoraria); Regeneron – Speaker/Faculty Education(Honoraria); Sanova Works – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria);